DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/t8zbx2/global_cardiac) has announced the addition of the... ...
http://www.asianhhm.com/press/pressrelease_archives.asp?PID=4631&title=Research-and-Markets-Global-Cardiac-Bio-Implant-Devices-Market-Forecast-Clinical-Trials-MampA(GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) today announced that it has priced an underwritten... ...
http://www.bizwireexpress.com/showstoryGNW.php?storyid=311062A new imaging substudy reveals that the Orsiro stent, which is a novel stent platform eluting sirolimus from a biodegradable polymer, demonstrated... ...
http://www.medindia.net/news/trial-finds-biodegradable-stent-is-non-inferior-to-drug-eluting-stent-119347-1.htmLONDON--Royalty Pharma AG, the New York-based pharmaceutical investor bidding around $6.4 billion in cash for drugmaker Elan Corp. (ELN) Thursday... ...
http://in.advfn.com/news_Royalty-Pharma-Lowers-Acceptance-Threshold-For-Elan-Offer_57702527.htmlAbbott Laboratories (ABT) recently announced that it received CE Mark in Europe for its drug eluting stent Xience Xpedition 48 Everolimus Eluting... ...
http://in.quote.com/news/zacksCache.aspx?id=708851